The Board has granted service connection for the Veteran's hypogammaglobulinemia, finding that it is secondary to his service-connected non-Hodgkin's lymphoma.
The deciding factor: The VA examiner opined that the Veteran's hypogammaglobulinemia is more likely than not due to his non-Hodgkin's lymphoma and medications used to treat it.
- Claimed conditions
- hypogammaglobulinemia
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- February 29, 2024
- Citation
- 24009910
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 24009910.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The appeal for a higher rating than 30 percent for hypogammaglobulinemia is remanded to obtain an addendum opinion regarding the severity of IVIG transfusions.
- Remanded (sent back)
The Veteran's initial rating for hypogammaglobulinemia is granted at a 30 percent level. The claim for service connection of migraine headaches is remanded.
- Remanded (sent back)
The Board has decided to remand the Veteran's claim for hypogammaglobulinemia as there are insufficient records and opinions regarding the etiology of his condition. The AOJ is required to obtain relevant medical records, including those from VA Choice Program providers, and provide an addendum opinion on the issue.
- Denied
The Board denied a rating higher than 30 percent for the Veteran's service-connected hypogammaglobulinemia, finding that his condition is best rated by analogy to agranulocytosis (Diagnostic Code 7702). The evidence showed effective treatment with monthly intravenous immunoglobulin (IVIG) therapy which reduced infections.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.